Ocular Therapeutix Inc (OCUL) Company Profile & Statistics

Ocular Therapeutix Inc
OCUL
(Nasdaq - US)
Closed
11.09
+0.31 (+2.88%)
in:usd•As of: Nov 08, 2024 15:59 UTC -5
Open
10.73
High
11.10
Low
10.64

About Ocular Therapeutix Inc

CEO

Antony Mattessich

Headquarters

15 crosby drive

bedford, ma 01730, united states

Auditor

PricewaterhouseCoopers LLP

Employees

267

Share Holders

Website

www.ocutx.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular Therapeutix, Inc. is headquartered in Bedford, Massachusetts.

Ocular Therapeutix Inc Statistics

Valuation Measures

Market Capitalization ²	1.73B
Enterprise Value	1.34B
Enterprise Value/EBITDA (ttm)	-12.07
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.49
Price to Sales (ttm)	27.92
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	90.84%
Operating Margin (ttm)	-190.95%
Profit Margin (ttm)	-226.51%
Return on Equity (ttm)	-52.75%
Return on Invested Capital (ttm)	-41.74%
Return on Assets (ttm)	-31.74%

Income Statement

Revenue (ttm)	61.10M
Revenue Per Share (ttm)	0.39
Gross Profit (ttm)	55.50M
EBITDA (ttm)³	-110.75M
Net Income Avi to Common (ttm)	-138.36M
Diluted EPS (ttm)	-1.35

Share Statistics

Beta (5Y Monthly)	1.26
52-Week Change	349.90%
S&P500 52-Week Change	36.80%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	155.92M
Dividend Yield	0.00%
Float ⁴	150.47M
% Held by Insiders	3.50%
% Held by Institutions	59.21%

Balance Sheet

Total Cash (mrq)	459.69M
Total Cash Per Share (mrq)	2.95
Total Debt (mrq)	67.13M
Total Debt/Equity (mrq)	17.77%
Current Ratio (mrq)	16.64%
Quick Ratio (mrq)	16.55%
Book Value Per Share (mrq)	2.43

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.35
Free Cash Flow (ytd)	-59.69M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Ocular Therapeutix Inc

Trade With A Regulated Broker